NEW YORK, Nov. 21, 2006 (PRIMEZONE) -- The cord blood and tissue banking operations of National Stem Cell Holding, Inc (Pink Sheets:NHGI) will be centralized under the newly-created subsidiary National Stem Cell Laboratory Services, Inc., a Maryland corporation. Based in Baltimore, the new company will manage National Stem Cell's umbilical cord blood banking initiative and will augment the tissue banking and reproductive services currently offered at its New York and New Jersey locations.
The development of the laboratory will be directed by Jacob Cohen, National Stem Cell COO and Ph.D. in Molecular Biology. "This new state-of-the-art facility will enhance our capacity for both processing and storage of cord blood and other tissue," Cohen stated, "and will be functionally designed to increase the breadth and depth of our stem cell research."
The National Stem Cell Laboratory Services facility will be located in close proximity to Johns Hopkins University, with whom the company maintains sponsored research agreements. The facility will be FDA, AABB, and AATB approved and cGMP/cGTP certified.
About National Stem Cell Holding, Inc.
National Stem Cell Holding, Inc. (Pink Sheets:NHGI) is a biotechnology company headquartered in New York City dedicated to the advancement of regenerative medicine. Incorporated in 2005, National Stem Cell Holding is the parent company National Stem Cell, Inc., which operates the Sperm Bank of New York as a wholly owned subsidiary. Through its sponsored research agreement with the Johns Hopkins University School of Medicine's Institute for Cell Engineering, National Stem Cell is focused on the development of potential stem cell therapies for the treatment of diabetes and cardiac injury. The company is developing a genetically diverse umbilical cord blood bank to meet the growing need for transplant grade umbilical cord blood stem cells. For more information, please visit www.nationalstemcell.com.
This press release contains forward-looking statements regarding the Company's financial or business outlook. Such statements are based on management's current beliefs and expectations. There are a number of risks and uncertainties that could cause actual results or events to differ materially from management's current beliefs and expectations. National Stem Cell Holding, Inc. does not undertake any obligation to update forward-looking statements.